<DOC>
	<DOCNO>NCT00569621</DOCNO>
	<brief_summary>It know several common eye disease associate ocular perfusion abnormality . Moxaverine use therapy perfusion abnormality brain , heart extremity direct vasodilatory effect . The present study seek investigate whether moxaverine alters ocular blood flow healthy volunteer intravenous administration .</brief_summary>
	<brief_title>A Randomized , Double-Masked , Placebo-Controlled Two Cross Over Study Comparing Effects Moxaverine Placebo Ocular Blood Flow</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Moxaverine</mesh_term>
	<mesh_term>Papaverine</mesh_term>
	<criteria>6 healthy volunteer either sex Age 1835 yr . Body mass index 15th 85th percentile , nonsmoker Regular use medication Abuse alcoholic beverage drug Participation clinical trial 3 week precede study Treatment previous 3 week drug Symptoms clinically relevant illness 3 week first study day History presence gastrointestinal , liver kidney disease , condition know interfere distribution , metabolism excretion study drug Blood donation previous 3 week Ametropy le 3 dpt Acute gastric bleeding , massive cerebral hemorrhage relate stroke Women : pregnancy lactation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>